“Or phase two early approval. They can approve based on…” — The a16z Show at 28:58
“Or phase two early approval. They can approve based on earlier trial results too. They are impressive. They found tons of ways to shorten the process to go from two miles to actually approving the drugs. And so you're just shortening the approval loops, right? And you're just taking out a bunch of kind of review…”
0:00
57:43